Citation: Ai. Green, SEX AND THE CITY (RESPONSE TO CRAIN,CALEB OVERVIEW OF THE HIGHLY CHARGES POLITICAL STRUGGLES WITHIN THE GAY AND LESBIAN COMMUNITY), Lingua franca, 8(1), 1998, pp. 88-88
Authors:
BERMAN I
MERSON A
VIEGNER B
LOSONCZY MF
PAPPAS D
GREEN AI
Citation: I. Berman et al., OBSESSIONS AND COMPULSIONS AS A DISTINCT CLUSTER OF SYMPTOMS IN SCHIZOPHRENIA - A NEUROPSYCHOLOGICAL STUDY, The Journal of nervous and mental disease, 186(3), 1998, pp. 150-156
Citation: Cm. Canuso et al., OLANZAPINE USE IN WOMEN WITH ANTIPSYCHOTIC-INDUCED HYPERPROLACTINEMIA, The American journal of psychiatry, 155(10), 1998, pp. 1458-1458
Authors:
KANDO JC
SHEPSKI JC
SATTERLEE W
PATEL JK
REAMS SG
GREEN AI
Citation: Jc. Kando et al., OLANZAPINE - A NEW ANTIPSYCHOTIC AGENT WITH EFFICACY IN THE MANAGEMENT OF SCHIZOPHRENIA, The Annals of pharmacotherapy, 31(11), 1997, pp. 1325-1334
Authors:
BERMAN I
VIEGNER B
MERSON A
ALLAN E
PAPPAS D
GREEN AI
Citation: I. Berman et al., DIFFERENTIAL RELATIONSHIPS BETWEEN POSITIVE AND NEGATIVE SYMPTOMS ANDNEUROPSYCHOLOGICAL DEFICITS IN SCHIZOPHRENIA, Schizophrenia research, 25(1), 1997, pp. 1-10
Authors:
STONE WS
SEIDMAN LJ
KALINOWSKI A
SHAGRIN B
PATEL JK
SHAFA R
CANUSO C
SCHILDKRAUT JJ
GREEN AI
Citation: Ws. Stone et al., EFFECTS OF CLOZAPINE ON COGNITIVE FUNCTIONS IN TREATMENT-REFRACTORY SCHIZOPHRENIA, Schizophrenia research, 24(1-2), 1997, pp. 188-189
Authors:
STROUS RD
FARAONE SV
RICHARDS C
YIN P
GUTIERREZ J
TSUANG MT
GREEN AI
Citation: Rd. Strous et al., TARDIVE-DYSKINESIA SCORES AS PREDICTOR OF RELAPSE WITH NEUROLEPTIC DOSE REDUCTION, Schizophrenia research, 24(1-2), 1997, pp. 273-273
Authors:
STROUS RD
FARAONE SV
YIN PY
GUTIERREZ JM
TSUANG MT
GREEN AI
Citation: Rd. Strous et al., THE PREDICTIVE VALUE OF TARDIVE-DYSKINESIA SCORES FOR RELAPSE WITH NEUROLEPTIC DOSE REDUCTION, Psychopharmacology bulletin, 33(3), 1997, pp. 590-590
Citation: Jk. Patel et al., CHRONIC-SCHIZOPHRENIA - RESPONSE TO CLOZAPINE, RISPERIDONE, AND PAROXETINE, The American journal of psychiatry, 154(4), 1997, pp. 543-546
Citation: Jk. Patel et al., EVALUATION OF A COMPLEX CASE - THE VALUE OF A DRUG WASHOUT PERIOD, The American journal of psychiatry, 154(12), 1997, pp. 1747-1750
Citation: Ai. Green et Jj. Schildkraut, SHOULD CLOZAPINE BE A FIRST-LINE TREATMENT FOR SCHIZOPHRENIA - THE RATIONALE FOR A DOUBLE-BLIND CLINICAL-TRIAL IN FIRST-EPISODE PATIENTS, Harvard review of psychiatry, 3(1), 1995, pp. 1-9
Authors:
BERMAN I
SAPERS BL
CHANG HHJ
LOSONCZY MF
SCHMILDLER J
GREEN AI
Citation: I. Berman et al., TREATMENT OF OBSESSIVE-COMPULSIVE SYMPTOMS IN SCHIZOPHRENIC-PATIENTS WITH CLOMIPRAMINE, Journal of clinical psychopharmacology, 15(3), 1995, pp. 206-210
Authors:
ALBANESE MJ
KHANTZIAN EJ
MURPHY SL
GREEN AI
Citation: Mj. Albanese et al., DECREASED SUBSTANCE USE IN CHRONICALLY PSYCHOTIC-PATIENTS TREATED WITH CLOZAPINE, The American journal of psychiatry, 151(5), 1994, pp. 780-781
Authors:
SEIDMAN LJ
PEPPLE JR
FARAONE SV
KREMEN WS
GREEN AI
BROWN WA
TSUANG MT
Citation: Lj. Seidman et al., NEUROPSYCHOLOGICAL PERFORMANCE IN CHRONIC-SCHIZOPHRENIA IN RESPONSE TO NEUROLEPTIC DOSE REDUCTION, Biological psychiatry, 33(8-9), 1993, pp. 575-584